Home
About Us
Structure
Current Events
Past Events
Policy & Reports
Awards
Membership
Media Coverage
Internship/Volunteers
Legal
Contact Us
 
 

USAIC has created an ecosystem committed to driving a global dialogue on BioPharma & Healthcare innovation, attracting a diverse mix of senior industry professionals and catalyzing partnerships, new ideas, networks and regulatory reform. This unique platform creates mutually beneficial opportunities and relationships for the global Life Sciences & Healthcare industry.

   
13th Annual BioPharma & Healthcare Summit, Thursday, May 9, 2019


BioPharma & Healthcare Summit - May 8, 2018

Chair and Emcee - Dr. Andrew Plump, Chief Medical & Scientific Officer, Takeda Pharmaceuticals

Time Topic
8-45 AM - 9-10 AM Registration and Networking
9-10 AM - 9-25 AM

Welcome address: Karun Rishi, President, USA-India Chamber of Commerce (USAIC)

Opening comments: Dr Andrew Plump, Chief Medical & Scientific Officer, Takeda Pharmaceuticals
9-25 AM - 10-15 AM

Panel Discussion: Industry-Academic Research Partnerships

Panelists:

  • Dr. Chas Bountra, Chief Scientist, Structural Genomics Consortium Oxford, University of Oxford
  • Dr. Jim Glasheen, Executive Vice Chancellor, University of Massachusetts Medical School
  • Dr. Jonathan Epstein, Executive Vice Dean & Chief Scientific Officer, Perelman School of Medicine, University of Pennsylvania
  • Dr. Nirmal Kumar Ganguly, President, Apollo Hospitals Educational & Research Foundation
  • Dr. Sridaran Natesan, Head - Strategic Initiatives & Scientific Relations, R&D, Sanofi North America

Moderator:
Juan Harrison, Vice President, Head of Strategic Academic Alliances, Takeda Pharmaceuticals

10-15 AM - 11-05 AM

Panel Discussion: Neuro Diseases                                                                                                          

Panelists:

  • Dr. Alfred Sandrock, Executive Vice President & Chief Medical Officer, Biogen
  • Dr. David Goldstein, Director, Institute for Genomic Medicine, Columbia University Medical Center
  • Dr. Maurizio Fava, Associate Dean, Clinical & Translational Research, Harvard Medical School
  • Dr. Meeta Chatterjee, Head, Business Strategy & Operations, Business Development & Licensing, Merck Research Labs
  • Dr. Steven Paul, President and Chief Executive Officer, Voyager Therapeutics

Moderator:
Dr. Steve Uden, Co-Founder, Rallybio

11-05 AM -11-35 AM Networking Break
11-35 AM - 12-25 PM

Panel Discussion: Oncology

Panelists:

  • Dr. Bruce Chabner, Director of Clinical Research, Mass General Hospital Cancer Center/Harvard Medical School
  • Dr. Kurt Stoeckli, President and Chief Scientific Officer, Glenmark Pharmaceuticals
  • Dr. Philip Rowlands, Head of the Oncology Therapeutic Area Unit, Takeda Pharmaceuticals
  • Dr. Victoria Richon, President & CEO, Ribon Therapeutics
  • Dr. Rakesh Jain, Director, E.L. Steele Laboratory of Tumor Biology,  Mass General Hospital Cancer Center/HMS

Moderator:
Dr. Raju Kucherlapati, Professor of Genetics, Harvard Medical School

12-25 PM - 1-00 PM

Fireside Chat:

  • Dr. Ansbert Gadicke, Founder & Managing Director, MPM Capital
  • Dr. Stelios Papadopoulos, Chairman, Biogen
  • Dr. Tsutomu Une, Senior Corporate Advisor, GCA Corporation

Moderator:
Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School

1-00 PM - 2-40 PM

Luncheon Panel Discussion: Technology Platforms

Panelists:

  • Chris Benko, Co-Founder & CEO, Koneksa Health
  • Colin Hill, Chairman & CEO, GNS Healthcare
  • Dr. Peter Mueller, Chairman, BioXcel Therapeutics
  • Dr. Shahram Ebadollahi, Vice President, Innovations & Chief Scientific Officer, IBM Watson Health Group, IBM
  • Dr. Vijay Chandru, Chairman, Strand Life Sciences

Moderator:
Dr. Ajay Dhankhar, Senior Partner, McKinsey and Company

2-40 PM - 3-15 PM Networking & Tea Break
3-15 PM - 3-35 PM

BioPharma: An Extraordinary Disruption

Dr. Ajay Dhankhar, Senior Partner, McKinsey and Company
Sastry Chilukuri, Partner, McKinsey and Company

3-35 PM - 4-30 PM

Panel Discussion: Drug Discovery and Development

Panelists:

  • Dr Andrew Plump, Chief Medical and Scientific Officer, Takeda Pharmaceuticals
  • Dr. Mathai Mammen, Global Head of R&D, Janssen Pharmaceutical- Johnson & Johnson
  • Dr. Michael Ehlers, Executive Vice President and Head of Research & Development, Biogen

Moderator:
Dr. Martin Mackay, Co-Founder and CEO, Rallybio

4-30 PM - 5-05 PM

Fireside Chat:

  • Dr. George Daley, Dean, Harvard Medical School
  • Dr. Susan Hockfield, President Emerita & Professor of Neuroscience, Massachusetts Institute of Technology (MIT)

Moderator:
Dr Andrew Plump, Chief Medical and Scientific Officer, Takeda Pharmaceuticals

5-05 PM - 5-10 PM Closing Remarks
5-10 PM - 6-30 PM Cocktails & Networking Reception


*Luncheon Panel Discussion: Lunch will be served at the table at 1 PM. Panel will start at 1:50 PM
* Speaker and Timings subject to change

Please keep your cell phones in the silent mode

Pharmasia News   Biospectrum India Online
 












Sanofi










Pharmasia News


Biospectrum India Online
© 2007 - USA India Chamber of Commerce Home | About us | Agenda | Council | Policy | Events | Photo Gallery | Awards | Membership | Membership Form | Internship/Volunteers | Legal | Contact us